All In Biotech

Drug Trial Radar · NCT04270591

Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer

A Phase Ib/II, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Glumetinib (SCC244), a Selective MET Inhibitor in Patients With Advanced Non-Small Cell Lung Cancer Harboring MET-alterations

Last checked: Nov 20, 2026Latest source record: Aug 1, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

183

Planned (sponsor's estimate)

Start

Jul 15, 2019

Primary completion

Oct 25, 2023

Study completion Dec 30, 2023

Sponsor

Lead sponsor
Haihe Biopharma Co., Ltd.Industry
Sponsor type
Industry
First posted
Feb 17, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Indication:Patients with Advanced c-MET-positive Non-Small Cell Lung Cancer Phase Ib (China only): Approximately 90 patients Phase Ⅱ (globally): Approximately 78 evaluable patients; addition of at least 6 patients in Safety Run-in (US only)

Conditions

  • C-Met Exon 14 Mutation

Interventions

  • GlumetinibDrug

    The investigational product will be orally administrated when fasting at dose level of 300mg QD

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ORRTime frame: through study completion, an average of 1 year

Locations

44 sites in 3 countries. Site status is shown where the registry gives one.

  • Norton Cancer Institute

    Louisville, Kentucky · Not yet recruiting

  • The Oncology Institute of Hope & Innovation

    Louisville, Kentucky · Recruiting

  • Hunan Province Cancer Hospital

    Changsha, China · Recruiting

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, China · Recruiting

  • Anhui Province Hospital

    Hefei, Anhui, China · Recruiting

  • The Chest Hospital of Anhui Province

    Hefei, Anhui, China · Recruiting

  • Beijing Cancer Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Beijing Cancer Hospita

    Beijing, Beijing Municipality, China · Recruiting

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Union Medical College Hospital Affiliated to Fujian Medical University

    Fuzhou, Fujian, China · Recruiting

  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China · Recruiting

  • Cancer Hospital Affiliated to Guangxi Medical University

    Nanning, Guangxi, China · Recruiting

  • Hainan Cancer Hospital

    Haikou, Hainan, China · Recruiting

  • Cancer Hospital Affiliated to Harbin Medical University

    Harbin, Heilongjiang, China · Recruiting

  • Henan Province Cancer Hospital

    Zhengzhou, Henan, China · Recruiting

  • Hubei Cancer Hospital

    Wuhan, Hubei, China · Recruiting

  • Wuhan Union Hospital

    Wuhan, Hubei, China · Recruiting

  • Xiangya Hospital Central South University

    Changsha, Hunan, China · Recruiting

  • Jiangsu Cancer Hospital

    Nanjing, Jiangsu, China · Recruiting

  • Jiangsu Province People's Hospital

    Nanjing, Jiangsu, China · Recruiting

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China · Recruiting

  • First Hospital of Jilin University

    Changchun, Jilin, China · Recruiting

  • Liaoning Cancer Hospital

    Shenyang, Liaoning, China · Recruiting

  • Affiliated Hospital of Hebei University

    Baoding, Shandong, China · Recruiting

  • Shandong University Qilu Hospital

    Jinan, Shandong, China · Recruiting

  • Changhai Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

  • Fudan university Shanghai cancer center

    Shanghai, Shanghai Municipality, China · Recruiting

  • The Chest Hospital of Shanghai

    Shanghai, Shanghai Municipality, China · Recruiting

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, China · Recruiting

  • Tianjin Cancer Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China · Recruiting

  • The First Affiliated Hospital,College of of Medicine, Zhejiang University

    Hangzhou, Zhejiang, China · Recruiting

  • Zhejiang Province Cancer Hospital

    Hangzhou, Zhejiang, China · Recruiting

  • Ehime University Hospital

    Ehime, Japan · Recruiting

  • Kyushu University Hospital

    Fukuoka, Japan · Recruiting

  • Kanagawa Cancer Center

    Kanagawa, Japan · Recruiting

  • Niigata Cancer Center Hospital

    Niigata, Japan · Recruiting

  • Kindai University Hospital

    Osaka, Japan · Recruiting

  • Osaka International Cancer Institute

    Osaka, Japan · Recruiting

  • Hokkaido University Hospital

    Sapporo, Japan · Recruiting

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.